DRUG BRIGHT MINDS BIOSCIENCES INC. Insider Trading

Cormorant Asset Management liquidates ~10% stake in Bright Minds Biosciences for ~$9.8M as stock rallies near highs.

Cormorant Asset Management, a large shareholder holding ten percent of Bright Minds Biosciences, sold roughly a tenth of its position shortly after the stock rallied sharply. The timing is notable: the stock has recovered strongly over recent weeks and is now trading just below its 52-week highs, yet the fund chose to exit a material portion of its holdings at these elevated levels rather than hold through. This is institutional portfolio management rather than insider knowledge-driven selling—Cormorant is rebalancing its position, not flagging internal concerns. However, the size of the sale ($9.8M) and the decision to reduce exposure near all-time prices suggests the fund may view current valuations as an attractive exit opportunity after strong momentum. For retail investors, this is a neutral signal: it reflects fund capital allocation, not management confidence or distress.

10% owner Cormorant Asset Management LP acquired 422,591 shares across 11 transactions for $3.2M (avg $7.65/sh) on Oct 15–16; stock now +1582.2% in 30d.

Cormorant Asset Management filed 11 separate purchases totaling 422,591 shares for $3,234,386.83 over two trading days (Oct 15–16), increasing its stake from 452,409 to 875,000 shares (+93.4%). The blended average price paid was $7.65, substantially below the current price of $21.70. The stock has surged +1582.2% over the past 30 days and +1770.7% over 90 days from historically depressed levels (52-week range $0.96–$38.49), suggesting the purchase may have been executed during a recovery from distressed valuation. However, the insider's cross-ticker track record shows prior open-market purchases averaging -26.8% return over 30 days and -37.1% over 90 days, with a 0% win rate on prior buys—a pattern that contrasts sharply with the dramatic recent upside in this specific stock. The volume and pricing ladder of the purchases (ranging from $4.53 to $25.22) suggests systematic accumulation rather than a single-block transaction.